Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin versus ciprofloxacin prophylaxis in allogeneic hematopoietic stem cell transplant recipients
IRCT20100127003210N17Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in bacterial disease comparing Levofloxacin with Ciprofloxacin (2 arms). Primary endpoints: Confirmed infection, Fever detection and 2 more. Started Feb 2019; status: completed.
02
Drugs
levofloxacinciprofloxacin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on IRCT20100127003210N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100127003210N17.